Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schallier

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Chest|October 1, 1983
Additive pulmonary toxicity with melphalan and busulfan therapyD Schallier, N Impens, F Warson, et al.
Anticancer Research|March 1, 1995
Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancerM T Closon, L Verbeke, J P Kains, et al.
Cancer Treatment Reports|May 1, 1984
Good response of a paraneoplastic neuromyopathy to cyclophosphamideM Bruyland, S Van Belle, D Schallier, et al.
European Neurology|January 1, 1986
Periventricular metastases of a primary intracranial alpha-fetoprotein-producing germ cell tumorM Bruyland, O Peters, D Schallier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2014
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patientsC Collen, N Christian, D Schallier, et al.
Journal of Immunology Research|June 2, 2018
The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal CancersY Gidron, M De Couck, D Schallier, et al.
Anticancer Research|June 9, 2001
Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC)P Glorieux, P Ortmanns, S Marien, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2007
A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC)D Schallier, B Neyns, C Fontaine, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)P Weynants, Y Humblet, A Bosly, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2008
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)L Decoster, D Schallier, H Everaert, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chest|October 1, 1983
Additive pulmonary toxicity with melphalan and busulfan therapyD Schallier, N Impens, F Warson, et al.
Anticancer Research|March 1, 1995
Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancerM T Closon, L Verbeke, J P Kains, et al.
Cancer Treatment Reports|May 1, 1984
Good response of a paraneoplastic neuromyopathy to cyclophosphamideM Bruyland, S Van Belle, D Schallier, et al.
European Neurology|January 1, 1986
Periventricular metastases of a primary intracranial alpha-fetoprotein-producing germ cell tumorM Bruyland, O Peters, D Schallier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2014
Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patientsC Collen, N Christian, D Schallier, et al.
Journal of Immunology Research|June 2, 2018
The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal CancersY Gidron, M De Couck, D Schallier, et al.
Anticancer Research|June 9, 2001
Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC)P Glorieux, P Ortmanns, S Marien, et al.
Lung Cancer (Amsterdam, Netherlands)|March 6, 2007
A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC)D Schallier, B Neyns, C Fontaine, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)P Weynants, Y Humblet, A Bosly, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2008
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)L Decoster, D Schallier, H Everaert, et al.
Pageof 3